# Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

> **NCT07276425** · — · RECRUITING · sponsor: **UMC Utrecht** · enrollment: 40 (estimated)

## Conditions studied

- Prurigo Nodularis (PN)

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT07276425
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276425, "Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07276425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*